These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35538419)

  • 1. Safety and efficacy of immediate heparin reversal with protamine after complex percutaneous coronary intervention.
    Choi JH; Chun KJ; Jung SM; Lee SY; Chon MK; Lee SH; Hwang KW; Kim JS; Park YH; Kim JH
    BMC Cardiovasc Disord; 2022 May; 22(1):207. PubMed ID: 35538419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of Reversing Anticoagulation by Protamine Following Elective Transfemoral Percutaneous Coronary Intervention in the Drug-Eluting Stent Era.
    Yamamoto S; Sakakura K; Taniguchi Y; Yamamoto K; Wada H; Momomura SI; Fujita H
    Int Heart J; 2018 May; 59(3):482-488. PubMed ID: 29743410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Protamine Administration for Prevention of Bleeding Complications in Patients Undergoing TAVR.
    Al-Kassou B; Kandt J; Lohde L; Shamekhi J; Sedaghat A; Tabata N; Weber M; Sugiura A; Fimmers R; Werner N; Grube E; Treede H; Nickenig G; Sinning JM
    JACC Cardiovasc Interv; 2020 Jun; 13(12):1471-1480. PubMed ID: 32553337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in high-bleeding-risk patients with acute coronary syndrome in contemporary practice.
    Zhang Y; Zhang Y; Liu Z; Zhang B; Liu G; Chen K
    Biomed Pharmacother; 2020 Oct; 130():110758. PubMed ID: 34321166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mid-term Clinical Outcomes of Immediate Protamine Use Following Elective Percutaneous Coronary Interventions.
    Kubota M; Sakakura K; Yamamoto K; Taniguchi Y; Tsukui T; Seguchi M; Wada H; Momomura SI; Fujita H
    Int Heart J; 2020 Sep; 61(5):865-871. PubMed ID: 32921667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of immediate reversal of anticoagulation by protamine to reduce bleeding complications after infarct artery stenting for acute myocardial infarction and adjunctive abciximab therapy.
    Parodi G; De Luca G; Moschi G; Bellandi B; Valenti R; Migliorini A; Carrabba N; Antoniucci D
    J Thromb Thrombolysis; 2010 Nov; 30(4):446-51. PubMed ID: 20571920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Via Radial Access Anticoagulated With Bivalirudin Versus Heparin: A Report From the National Cardiovascular Data Registry.
    Jovin IS; Shah RM; Patel DB; Rao SV; Baklanov DV; Moussa I; Kennedy KF; Secemsky EA; Yeh RW; Kontos MC; Vetrovec GW
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1102-1111. PubMed ID: 28527778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and safety of bivalirudin in elderly patients with coronary artery disease undergoing percutaneous coronary intervention: A real-world study.
    Li J; Liu X; Ma S; Na K; Qi Z; Xu Y; Qiu M; Han Y; Li Y
    Catheter Cardiovasc Interv; 2022 May; 99 Suppl 1():1448-1455. PubMed ID: 35077603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate removal of femoral-sheath following protamine administration in patients undergoing intracoronary paclitaxel-eluting-stent implantation.
    Rossi ML; Zavalloni D; Scatturin M; Gasparini GL; Lisignoli V; Presbitero P
    Expert Opin Pharmacother; 2007 Sep; 8(13):2017-24. PubMed ID: 17714056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging role of adopting protamine for reducing the risk of bleeding complications during the percutaneous coronary intervention: A meta-analysis.
    Jiang Y; Liu Y; Jia X; Xin W; Wang H
    J Card Surg; 2022 Dec; 37(12):5341-5350. PubMed ID: 36352811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.
    Valgimigli M; Frigoli E; Leonardi S; Vranckx P; Rothenbühler M; Tebaldi M; Varbella F; Calabrò P; Garducci S; Rubartelli P; Briguori C; Andó G; Ferrario M; Limbruno U; Garbo R; Sganzerla P; Russo F; Nazzaro M; Lupi A; Cortese B; Ausiello A; Ierna S; Esposito G; Ferrante G; Santarelli A; Sardella G; de Cesare N; Tosi P; van 't Hof A; Omerovic E; Brugaletta S; Windecker S; Heg D; Jüni P;
    Lancet; 2018 Sep; 392(10150):835-848. PubMed ID: 30153988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency and safety of bivalirudin in patients undergoing emergency percutaneous coronary intervention via radial access: A subgroup analysis from the bivalirudin in acute myocardial infarction versus heparin and GPI plus heparin trial.
    Wang H; Li Y; Cong H; Ding S; Liu B; Li L; Chen Y; Jia S; Jing Q; Zhao X; Liu H; Liang Z; Li J; Bao D; Han Y
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1157-1165. PubMed ID: 27677411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of anti-thrombotic strategies using Bivalirudin, Heparin plus Glycoprotein IIb/IIIa inhibitors and Unfractionated Heparin Monotherapy for patients undergoing percutaneous coronary intervention - A single centre observational study.
    Kaul U; Dua A; Sethi AK; Arambam P; Seth A
    Indian Heart J; 2015; 67(4):311-7. PubMed ID: 26304562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protamine use in transcarotid artery revascularization is associated with lower risk of bleeding complications without higher risk of thromboembolic events.
    Liang P; Motaganahalli RL; Malas MB; Wang GJ; Eldrup-Jorgensen J; Cronenwett JL; Nolan BW; Kashyap VS; Schermerhorn ML
    J Vasc Surg; 2020 Dec; 72(6):2079-2087. PubMed ID: 32273225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editor's Choice - Protamine Reduces Serious Bleeding Complications Associated with Carotid Endarterectomy in Asymptomatic Patients without Increasing the Risk of Stroke, Myocardial Infarction, or Death in a Large National Analysis.
    Stone DH; Giles KA; Kubilis P; Suckow BD; Goodney PP; Huber TS; Powell RJ; Cronenwett JL; Scali ST
    Eur J Vasc Endovasc Surg; 2020 Dec; 60(6):800-807. PubMed ID: 33127243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unfractionated Heparin with Sequential Enoxaparin in Patients with Complex Coronary Artery Lesions during Percutaneous Coronary Intervention.
    Li ZZ; Tao Y; Wang S; Yin CQ; Gao YL; Cheng YT; Li Z; Ma CS
    Chin Med J (Engl); 2018 Oct; 131(20):2417-2423. PubMed ID: 30334526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of short-time anticoagulant therapy after selective percutaneous intervention on prognosis of patients with coronary artery disease].
    Song Y; Tang XF; Xu JJ; Wang HH; Liu R; Jiang P; Jiang L; Gao LJ; Zhang Y; Song L; Xu LJ; Zhao XY; Gao Z; Chen J; Gao RL; Qiao SB; Yang YJ; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Feb; 47(2):108-116. PubMed ID: 30818938
    [No Abstract]   [Full Text] [Related]  

  • 18. Protamine use in transfemoral carotid artery stenting is not associated with an increased risk of thromboembolic events.
    Liang P; Motaganahalli R; Swerdlow NJ; Dansey K; Varkevisser RRB; Li C; Lu J; de Guerre L; Shuja F; Schermerhorn M
    J Vasc Surg; 2021 Jan; 73(1):142-150.e4. PubMed ID: 32535154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protamine sulfate use during tibial bypass does not appear to increase thrombotic events or affect short-term graft patency.
    Phair J; Futchko J; Trestman EB; Carnevale M; Friedmann P; Shukla H; Garg K; Koleilat I
    Vascular; 2020 Dec; 28(6):708-714. PubMed ID: 32393108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of coronary angiography and percutaneous coronary intervention via the radial versus femoral route in patients on uninterrupted oral anticoagulation with warfarin.
    Baker NC; O'Connell EW; Htun WW; Sun H; Green SM; Skelding KA; Blankenship JC; Scott TD; Berger PB
    Am Heart J; 2014 Oct; 168(4):537-44. PubMed ID: 25262264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.